Editors' Note: Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis. [PDF]
Siegler JE, Galetta S.
europepmc +1 more source
Efficacy and safety of pharmacological treatments in inclusion body myositis: a systematic review. [PDF]
Santos EJF +5 more
europepmc +1 more source
Reply to: "Before Coming to the Conclusion That Inclusion Body Myositis Is a Risk Factor for a Heart Attack, All Influencing Factors Must Be Taken Into Account". [PDF]
Naddaf E.
europepmc +1 more source
NLRP3 Inflammasome Activation and Altered Mitophagy Are Key Pathways in Inclusion Body Myositis. [PDF]
Naddaf E +11 more
europepmc +1 more source
Before Coming to the Conclusion That Inclusion Body Myositis Is a Risk Factor for a Heart Attack, All Influencing Factors Must Be Taken Into Account. [PDF]
Finsterer J, Zarrouk S.
europepmc +1 more source
Whole-body-electro-myostimulation for the care of inclusion body myositis-A case report. [PDF]
Freitag N +6 more
europepmc +1 more source
Human induced pluripotent stem cell-derived myotubes to model inclusion body myositis. [PDF]
Cantó-Santos J +19 more
europepmc +1 more source
A fatal case of disseminated microsporidiosis due to Anncaliia algerae in a renal and pancreas allograft recipient [PDF]
Anderson, Neil W +9 more
core +1 more source
Strapped for Strength: A Comparison Study of Dynamometry Techniques to Evaluate Knee Extensor Strength in Inclusion Body Myositis. [PDF]
Schütze K +7 more
europepmc +1 more source
Intramyocardial fatty infiltration lesion in sporadic inclusion body myositis: a case report. [PDF]
Redzepi B +8 more
europepmc +1 more source

